Favorable Clinical Course of Patients Experiencing Bevacizumab-Induced Proteinuria

Nephrotic-range proteinuria, which denotes structural damage to the glomerular filtration barrier, occurs in 1–2% of bevacizumab-treated patients. The glomerular injury and subsequent proteinuria is probably due to a direct targeting of vascular endothelial growth factor (VEGF). We report a case ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Saloustros, Emmanouil, Androulakis, Nikolaos, Vamvakas, Lambros, Mavroudis, Dimitris, Georgoulias, Vassilis
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: October 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085070/
https://www.ncbi.nlm.nih.gov/pubmed/21537380
http://dx.doi.org/10.1159/000321630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085070/
https://www.ncbi.nlm.nih.gov/pubmed/21537380
http://dx.doi.org/10.1159/000321630

Ejemplares similares